Legal and Compliance

Engineering and Development

VP Program Management

TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced Enrollment

TG Therapeutics says enrollment commenced for Phase 3 trial of BRIUMVI

TG Therapeutics CEO Voices Strong Conviction In Briumvi With New $100 Million Buyback

TG Therapeutics, Inc. announces an Equity Buyback for $100 million worth of its shares.

Senior Director, Head of Regulatory Affairs

TG Therapeutics is a fully-integrated biopharmaceutical company focused on developing treatments for B-cell diseases. They are seeking a Senior Director, Head of Regulatory Affairs to shape and execute the global regulatory strategy across their portfolio, serving as the primary liaison with regulatory agencies and providing executive-level guidance on regulatory matters.

Senior Vice President-Legal Affairs

Associate Director, Global Regulatory Affairs

Sign up with Google

Sign in with Google